Source BioScience is a Biotechnology company with an expertise in the development and validation of biomarkers for use as companion diagnostics to support new drug launches or as endpoints for clinical and FDA studies.

We also provide pharmacogenomic and clinical testing services, supporting pre-clinical & clinical trials for different therapeutic areas, with an expertise in Cancer.

The emerging interest in "pharmacogenomics" is comprehensively covered to aid the clinical development of new diagnostic, prognostic and predictive tests as well as supporting drug development pipeline studies from target identification through to clinical trials.

Source BioScience is GLP, GCP and CPA accredited (comparable to CAP, CLIA), with five laboratories throughout the UK and Eire, and a further laboratory based in Berlin, providing global clinical trial support. We are the biggest genomics and pathology service provider in the UK and one of only ten labs worldwide with CsPro accreditation for excellence in next generation sequencing, awarded by Illumina.